Movers and Shakers Leading Today Market Buzz

 Top.Gainers
 
  Top.Gainers
 
Follow  Message
 
 
 
Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
 

•  17 Nov 2025
 

•   ANRO  
   
  -0.86%
•   CNTB  
   
  -3.60%
•   GPUS  
   
  -8.33%
•   ICU  
   
  0.00%
•   IVVD  
   
  -11.03%

$VSTM is leading todays charge, surging 21.11% as technical indicators signal a potential bullish reversal. The Aroon Down crossing above the Aroon Up is catching the attention of momentum traders who see this as a key inflection point. Coupled with heavy volume, nearly double its average, investors are betting that VolitionRx market sentiment could continue its upward trajectory at least in the short term.

$IVVD is climbing 20.85% following a significant analyst upgrade. Invivyd one-year price target has been raised 29.41% to $7.48 from $5.78 just ten days ago, fueling renewed optimism around the stock. The spike in trading volume, more than twice its average, reflects strong investor interest as traders speculate on the potential impact of this positive outlook on the companys near-term performance.

$CNTB is up 16.51% after Connect Biopharma received a price target boost to $7.78, an 11.59% increase from prior estimates. This gain is amplified by unusual volume activity, with daily trading volume far exceeding the norm. Investors appear encouraged by the fundamentals and potential catalysts, seeing the upgrade as a signal that the stock could have room to run in upcoming sessions.

$ANRO has captured attention with a 13.96% jump following its initiation as a Buy by BTIG. The analyst highlighted Alto Neurosciences precision psychiatry approach as a key differentiator, sparking interest among growth-focused traders. This move underscores the markets appetite for early-stage biotech names that combine innovative treatments with promising growth potential, even as volume remains modest relative to other names on the list.

$JKS is rallying 13.64% despite mixed financial results. JinkoSolar reported a Q3 loss of $105.32 million, missing revenue expectations by $450 million. However, traders seem focused on the broader growth narrative and upcoming Annual General Meeting, betting that longer-term solar expansion prospects outweigh short-term setbacks. Heavy trading volume indicates robust interest, suggesting momentum-driven buying is sustaining todays gains.

On the downside,
$YSG is down 20.32%, reflecting disappointment following its Q3 earnings release. Despite revenue growth, the company reported a GAAP EPS of -$0.07, prompting investors to sell. $ICU dropped 20.26% after announcing a CFO appointment, a move interpreted by some as a signal of internal challenges. $ONFO, $MNTS, and $GPUS also saw steep declines, driven largely by consecutive down days and weak investor sentiment.

View All Headlines